WHO Director Lays Out Vision Of Transformation To ‘Agile’, Transparent Agency 24/01/2019 William New World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) today explained details of fundamental changes being set in motion at the UN agency, including greater impact, increased staff work and training at the country level, producing 'world class' work, more transparency, and digital health and innovation. In his opening remarks to the WHO Executive Board, he listed recent accomplishments and devoted significant attention to staffing issues at a time when unconfirmed reports of alleged misconduct have been circulating. Continue reading -> G-Finder: R&D Investments Reach 10-Year Peak 23/01/2019 Health Policy Watch Funding for neglected disease research and development reached its highest level in a decade, with US $3.56 billion in investments in 2017. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
G-Finder: R&D Investments Reach 10-Year Peak 23/01/2019 Health Policy Watch Funding for neglected disease research and development reached its highest level in a decade, with US $3.56 billion in investments in 2017. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Single Dose Drug Effective For Recurrent Malaria, Trial Results Show 17/01/2019 Editorial team A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading -> Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Criminalisation Of HIV/AIDS Transmission Undermining Efforts To Combat The Disease, Panellists Say 20/12/2018 Justus Wanzala Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading -> Posts navigation Older postsNewer posts